Compare · MBAI vs NNOX
MBAI vs NNOX
Side-by-side comparison of Check-Cap Ltd. (MBAI) and NANO-X IMAGING LTD (NNOX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MBAI and NNOX operate in Medical Electronics (Health Care), so they compete in similar markets.
- NNOX is the larger of the two at $72.4M, about 10.3x MBAI ($7.0M).
- Over the past year, MBAI is up 40.1% and NNOX is down 77.6% - MBAI leads by 117.7 points.
- MBAI has been more active in the news (4 items in the past 4 weeks vs 3 for NNOX).
- NNOX has more recent analyst coverage (4 ratings vs 0 for MBAI).
- Company
- Check-Cap Ltd.
- NANO-X IMAGING LTD
- Price
- $1.03+0.00%
- $1.14+5.56%
- Market cap
- $7.0M
- $72.4M
- 1M return
- -28.97%
- -33.72%
- 1Y return
- +40.14%
- -77.56%
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2015
- 2020
- News (4w)
- 4
- 3
- Recent ratings
- 0
- 4
NANO-X IMAGING LTD
Nano-X Imaging Ltd., a development-stage company, develops, produces, and commercializes digital X-ray source technology for the medical imaging industry worldwide. Its X-ray source is based on a novel digital MEMs semiconductor cathode. The company also develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Neve Ilan, Israel.
Latest MBAI
- Check-Cap: MBody AI Advances Its Robot Fleet Operating System with Multi-Robot Control
- Check-Cap: MBody AI Brings AI Robotics to Buyers Edge Platform Operators, Manufacturers and Distributors
- SEC Form 6-K filed by Check-Cap Ltd.
- Amendment: SEC Form 6-K/A filed by Check-Cap Ltd.
- SEC Form EFFECT filed by Check-Cap Ltd.
- SEC Form POS AM filed by Check-Cap Ltd.
- SEC Form POS AM filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 20-F filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
Latest NNOX
- Nano-X Imaging downgraded by Alliance Global Partners with a new price target
- New Clinical Study Data, Featuring Nanox.AI Cardiac Solution to Be Presented at SCCT 2026
- SEC Form 6-K filed by NANO-X IMAGING LTD
- Director Alroy Erez sold $1,119 worth of Ordinary Shares (678 units at $1.65), increasing direct ownership by 145% to 17,075 units (SEC Form 4)
- Nanox to Report First Quarter 2026 Financial Results on June 25, 2026
- Exclusive distribution agreement marks Nanox's entry into the Peruvian market
- Amendment: SEC Form SCHEDULE 13G/A filed by NANO-X IMAGING LTD
- Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities
- Nanox Announces Distribution Agreement with NuvioDx to Support Deployment of Nanox.ARC Systems
- SEC Form 20-F filed by NANO-X IMAGING LTD